Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Lung Neoplasms 2 Urinary Bladder Neoplasms 1 Terminal Cancer 1 Solid Tumor 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Postoperative Cognitive Complications 1 Polyps 1 Patient Satisfaction 1 Pancreatitis 1 Pancreatic Neoplasms 1 Pain, Postoperative 1 Pain 1 Mouth Neoplasms 1 Gastrointestinal Stromal Tumors 1 Fractures, Bone 1 Colonic Neoplasms 1 Choledocholithiasis 1 Choledochal Cyst 1 Cholangiocarcinoma 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Anxiety Disorders 1

Interventions

Midazolam 1 Fentanyl 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Terminal Cancer × Midazolam × Clear all

NCT02009306 2018-05-09

Nasal Fentanyl and Buccal Midazolam for Dying Patients

Gloucestershire Hospitals NHS Foundation Trust

Phase 4 Completed

Terminal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡